KSPWFTTL (TFA)
KSPWFTTL TFA is an immunodominant Kb-restricted epitope from the p15E transmembrane protein. KSPWFTTL TFA can restore susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes[1][2].
Product Specifications
UNSPSC
12352209
Target
MHC
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/kspwfttl-tfa.html
Purity
99.32
Solubility
H2O : 66.67 mg/mL (ultrasonic)
Smiles
O=C([C@H]1N(CCC1)C([C@H](CO)NC([C@@H](N)CCCCN)=O)=O)N[C@H](C(N[C@H](C(N[C@@H]([C@H](O)C)C(N[C@@H]([C@H](O)C)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)CC2=CC=CC=C2)=O)CC3=CNC4=CC=CC=C34.O=C(O)C(F)(F)F
Molecular Formula
C50H71F3N10O14
Molecular Weight
1093.15
References & Citations
[1]White HD, et, al. An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes. J Virol. 1994 Feb;68 (2) :897-904.|[2]Rich RF, et, al. Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4 (+) and CD8 (+) antiviral T cells by viral antigen-positive veto cells. J Virol. 1999 May;73 (5) :3826-34.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP312761M 100 µg
MTH1 (NUDT1) (NM_198950) Human Recombinant Protein
Sign In for Pricing
View Details ![5-Allylidene-10,11-dihydro-5H-dibenzo[a,d][7]annulene (Stabilized with Hydroquinone)](https://cdn.genprice.uk/products/572/6490864143476/imageurl/trc-a552600-10mg.webp)
TRC-A552600-10MG 10 mg
5-Allylidene-10,11-dihydro-5H-dibenzo[a,d][7]annulene (Stabilized with Hydroquinone)
Sign In for Pricing
View Details